The impact of Regional co-payment and National reimbursement criteria on statins use in Italy: an interrupted time-series analysis

Impact of regional copayment policy on selective serotonin reuptake inhibitor (SSRI) consumption and expenditure in Italy

(2012) Gianfranco Damiani et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Impact of Prior Authorization on the Use and Costs of Lipid-Lowering Medications Among Michigan and Indiana Dual Enrollees in Medicaid and Medicare: Results of a Longitudinal, Population-Based Study

(2011) Christine Y. Lu et al.   CLINICAL THERAPEUTICS

A Pharmaceutical Care Program to Improve Adherence to Statin Therapy: A Randomized Controlled Trial

(2010) Simone RBM Eussen et al.   ANNALS OF PHARMACOTHERAPY

Impact of Restricted Reimbursement on the Use of Statins in Finland

(2010) Jaana E. Martikainen et al.   MEDICAL CARE

Impact of reimbursement changes on statin use among patients with diabetes in Austria

(2010) Wolfgang C. Winkelmayer et al.   WIENER KLINISCHE WOCHENSCHRIFT

Statin treatment after a recent TIA or stroke: is effectiveness shown in randomized clinical trials also observed in everyday clinical practice?

(2009) H. F. Lingsma et al.   ACTA NEUROLOGICA SCANDINAVICA

The Last Decade of Italian Pharmaceutical Policy

(2009) Giovanni Fattore et al.   PHARMACOECONOMICS

Lipid-lowering drug use in Italian primary care: effects of reimbursement criteria revision

(2008) G. Trifirò et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Adherence to statin therapy and patients’ cardiovascular risk: a pharmacoepidemiological study in Italy

(2008) Elisabetta Poluzzi et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY